• Maqbool Ilahi
  • Jehanzeb Khan
  • Qaiser Inayat
  • Tuqqaya Sultana Abidi


Background: Indomethacin, a non-steriodalanti-inflammatory drug, is used mainly for thetreatment of painful joints such as rehumatoid arthritis, osteo–arhtritis, gout, ankylosingspondylitis etc. It relieves pain, reduces swelling and tenderness of the joints. It also inducesulceration of stomach and small intestine both in experimental animals and humans. Material andMethods: In this study indomethacin was given intrapertioneally in maximum therapeutic dose (4mg/Kg body weight) to three experimental groups B, C and D for one, two and three weeksrespectively. Group A was the control group. Results: Effects were observed in stomach pylorusand proximal duodenum. In the stomach pylorus, well defined superficial ulcers were identifiedduring initial two weeks of drug administration. The ulcer penetrated as for as muscularis mucosaeand ulcer bed had coagulative necrosis and inflammatory cells. During third week, stomachpylorus showed minor damage in the form of focal necrosis. Duodenum was affected less thanstomach and showed villi with lost tips, tilted and distorted villi. Morphometric analysis showedchanges in stomach pylorus and in duodenum. The number of mitotic figure was significantlyincreased in stomach pylorus. Duodenum showed insignificant to significant decrease in the heightof villi. Increase in the number of goblet cells, columnar cells, and mitotic figure was also noted;which was undoubtedly part of the tissue response to an injury. Conclusion: These observationssuggested that indomethacin given in a ma ximum therapeutic dose, initially induces lesions instomach pylorus and proximal duodenum but almost no effects were noted when duration of thedrug administration was prolonged.Key Words: Indomethacin, Stomach, Duodenum.


Robbin SL, Kumar V, Ramzi C. Acute and chronic

inflammation In: Basic pathology. 7th edition. Philadelphia.

W.B. Company, 2003: page 333.

Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K.

Inhibition of both COX-1 and COX-2 is required for

development of gastric damage in response to nosteroidal

anti-inflammatory drugs. J Physiol Paris2001;95(1-6):21-7.

Basivireddy J, Jacob M, Balasubramanian KA. Indomethacin induced small intestinal damage is attenuated by oral

glutamine. London Clin Sci 2004;107(3):281-9.

Sigthorsson G, Jacob M, Wriggles Worth J, Rafi S,

Mahmud T, Simpson R, et al. Comparison of indomethacin

and nimesulide, a selective cycloxygenase – 2 inhibitor, on

key pathophysiologic steps in the pathogenesis of

nonsteroidal anti-inflammatory drug enteropathy in the rat.

Scand J Gastroenterol 1998; 33: 728-35.

Gilman G. Analgesics anti-pyretics anti-inflammatory

agents In: The pharmacological basis of therapeutics. Tenth

edition Singapore Maxwell Macmillan Publishing.2001;pp.


Laurence DR, Bannett PN. Inflammation and non-steroidal

anti-inflammatory drugs In: Clinical pharmacology sixth

edition. UK Chruchill Livingstone, 1988: pp 289.

Seth SD. Analgesic antipyretic and anti-inflammatory drugs

In: Textbook of pharmacology. Second edition. New Delhi

Churchill Livingstone, 2000: pp 1-6, 170-71.

Ritter, Lewis, Mant. Anti-inflammatory drugs and treatment

of arthritis. In: Clinical pharmacology. 3rd edition London,

Edward Arnold, 1995: page 250.

Klautz RJ, Van-Bel F, Teitel DF, Steendjik P, Baan J.

Myocardial perfusion and performance after indomethacin

administration in newborn lambs. United States Pediatr-Res

;33(3): 295-301.

Swift GI, Arnold J, Williams GT, William BD, Rhodes J,

Khan F. A comparison of upper gastrointestinal mucosal

damage by standard and delayed release indomethacin.

England Aliment Pharmacol Ther 1992; 6(6): 717-25.

Dennis & McNamara. Non-opiate analgesics and antiinflammatory drugs. In: Principles of pharmacology.

Edition 1995 USA. Chapman and Hall, 1995; page 1175.

Anthony A, Sim R, Dhillon AP, Pounder RE, Wakefield

AJ. Gastric mucosal contraction and vascular injury induced

by indomethacin precede neutrophil infiltration in the rat.

England Gut 1996; 39(3): 363-368.

Fang FW, Bronthton A, Eugene D. Jacobson. Indomethacin

induced gastric and intestinal inflammation. Am J Diges

; 22(9): 749-60.

Karatani K, Kodama H, Yamaguchi I. Indomethacin

induced antral ulcer in the rat. USA J Pharmacol Exp. Ther


Satoh H, Guth PH. Role of gastric acid and prostaglandins

in the formation of gastric antral ulcers produced by

indomethacin in the rat USA Prostaglandins 1981;21:131-7.

Satoh H, Inada I, Hirata T, Maki Y. Indomethacin produces

gastric antral ulcers in the refed rat. USA. Gastroenterology

; 81(4): 719-25.

Ettarh RR, Carr KE. Structural and morphometric analysis

of murine small intestine after indomethacin administration.

Scand J Gastroenterol 1993; 28: 795-802.

Mahendran P, Vanisree AJ, Shymala D. Indomethacin

induced gastric ulcer in rats and antiulcer activity of

Garcinia cambogia. Phyother – Res UK 2002;16(1): 80-3.

J Ayub Med Coll Abbottabad 2006;18(3)

Olivero JJ, Graham DY. Gastric adaptation to nonsteriodal

anti-inflammatory drugs in man. Scand J Gastroenterol

; 27 Supp 193: 52-58.

Ettarh RR, Carr KE. Morphometric analysis of small

intestinal epithelium in the indomethacin treated mouse. UK

J Anat 1996;189: 51-56.

Chirsopther J, Shorrock RJ, Prescott. The effects of

indomethacin on gastroduodenal morphology and mucosal

pH gradient in the healthy human stomach.

Gastroenterology 1990; 99: 334-39.

Garcia Rodriguez LA, Jick H. Risk of upper

Gastrointestinal bleeding and perforation associated with

individual non-steroidal anti-inflammatory drugs. Lancet

; 343: 769-72.